Laobaixing Pharmacy (603883) — Cash Flow-to-Debt Ratio
Laobaixing Pharmacy (603883) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥538.25 Million could theoretically repay 0% of its total liabilities (CN¥13.13 Billion) in one year. See how much free cash does Laobaixing Pharmacy generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Laobaixing Pharmacy Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Laobaixing Pharmacy across 15 annual periods. Also explore how fast is Laobaixing Pharmacy growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Laobaixing Pharmacy (2011–2025)
Year-by-year debt coverage analysis for Laobaixing Pharmacy. For market capitalisation and broader financial context, see 603883 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | CN¥3.14 Billion | CN¥12.85 Billion | ▲ +80.9% |
| 2024 | 0.14x | CN¥2.03 Billion | CN¥14.99 Billion | ▼ -31.0% |
| 2023 | 0.20x | CN¥2.73 Billion | CN¥13.94 Billion | ▲ +21.0% |
| 2022 | 0.16x | CN¥2.31 Billion | CN¥14.30 Billion | ▼ -14.2% |
| 2021 | 0.19x | CN¥2.30 Billion | CN¥12.18 Billion | ▼ -15.5% |
| 2020 | 0.22x | CN¥1.45 Billion | CN¥6.48 Billion | ▲ +30.9% |
| 2019 | 0.17x | CN¥1.03 Billion | CN¥6.05 Billion | ▼ -4.4% |
| 2018 | 0.18x | CN¥913.03 Million | CN¥5.12 Billion | ▲ +30.5% |
| 2017 | 0.14x | CN¥492.13 Million | CN¥3.60 Billion | ▲ +29.4% |
| 2016 | 0.11x | CN¥313.26 Million | CN¥2.96 Billion | ▼ -38.0% |
| 2015 | 0.17x | CN¥257.15 Million | CN¥1.51 Billion | ▼ -0.4% |
| 2014 | 0.17x | CN¥247.14 Million | CN¥1.44 Billion | ▲ +58.4% |
| 2013 | 0.11x | CN¥136.52 Million | CN¥1.26 Billion | ▼ -35.9% |
| 2012 | 0.17x | CN¥148.85 Million | CN¥882.72 Million | ▲ +16.1% |
| 2011 | 0.15x | CN¥132.62 Million | CN¥912.83 Million | — |